Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (DRKS00040884) titled 'EmpAItica: AI-Based Prediction of Fear Responses in Spider Phobia Using Virtual Reality (VR)' on July 23.
Study Type: interventional
Study Design:
Allocation: Non-randomized controlled study
Masking: Open (masking not used)
Control: active
Assignment: parallel
Study design purpose: diagnostic
Primary Sponsor: Hochschule Reutlingen
Condition:
F40.2
Specific (isolated) phobias
Intervention:
Group 1: Adults aged 18 to 65 years with a diagnosis of specific phobia, spider type, established using the Mini-DIPS diagnostic interview. Participants undergo an online screening to assess eligibility, a diagnostic assessmen...